NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells. Issue 9 (3rd May 2017)

• Record Type: Journal Article
• Authors: Feng, Shaoyan; Yang, Guangwei; Yang, Haidi; Liang, Zibin; Zhang, Rongkai; Fan, Yunping; Zhang, Gehua
• Is Part Of: Cell cycle. Volume 16:Issue 9(2017)
• Page Start: 869
• Page End: 878
• Publication Date: 2017-05-03
• Subjects: drug resistance -- EMT -- Nasopharyngeal carcinoma -- NEDD4; Cell cycle -- Periodicals; 571.84377
• DOI: 10.1080/15384101.2017.1308617
• Languages: English
• ISSNs: 1538-4101

Abstract

ABSTRACT: Nasopharyngeal carcinoma (NPC) is a highly invasive head-neck cancer derived from the nasopharyngeal epithelium, mainly prevalent in southern China and Southeast Asia. Radiotherapy and adjuvant cisplatin (DDP) chemotherapy are standard administrations applied in the treatment of NPC. However, resistance to chemotherapeutic drugs has recently become more common, resulting in worse treatment outcome for NPC therapy. To elucidate the underlying molecular basis of drug resistance to DDP in NPC cells, we examined the morphocytology, cell motility and molecular changes in DDP-resistant NPC cells with respect to epithelial-mesenchymal transition (EMT) features. We found that EMT is closely associated with DDP-induced drug resistance in NPC cells, as DDP-resistant cells displayed morphological and molecular markers changes consistent with EMT. Wound healing and Transwell Boyden chamber assays revealed an enhanced migration and invasion potential in DDP-resistant NPC cells. Mechanistically, upregulation of NEDD4 was observed to relate to EMT in DDP-resistant cells. More importantly, depletion of NEDD4 in resistant cells led to a partial reversion of EMT phenotypes to MET characteristics. These data suggest that NEDD4 is largely involved in EMT features and chemoresistance of NPC cancer cells. NEDD4 could be a novel therapeutic target to overcome drug resistance in successful administrations of NPC.